Geisinger Research

🔔#MyCode Genomic Screening and Counseling Program Grand Rounds

"Frameworks to guide population genomic screening programs in gene selection and implementation"

Presented by: Adam H. Buchanan, MS, MPH, CGC, Professor and Chair, Department of Genomic Health, College of Health Sciences, Geisinger and Caitlin G. Allen, PhD, MPH, Associate Professor, Department of Implementation Science, Wake Forest University School of Medicine

🗓️November 9th
🕛12:00-1:00 PM ET
CME Credit Available

We know genetics can influence how people respond to medications, but how often does that affect care in the real world?

In a recent study, researchers analyzed genomic and electronic health record data from more than 226,000 participants in Geisinger's MyCode to better understand the impact of genetics on adverse drug reactions.

Key findings:
🧬93.7% of patients carried at least one genetic variant that could affect medication response.
💊More than 44% were prescribed a medication that conflicted with their genetic risk profile.
👨‍👩‍👧‍👦Patients with a genetic mismatch were 1.4 times more likely to experience an adverse drug reaction.
📄These mismatches accounted for nearly 30% of adverse drug reactions observed.

Integrating pharmacogenomic testing into routine care could help identify medication risks earlier and prevent adverse drug reactions before a patient takes their first dose.

sciencedirect.com/science/articl…

🗣️Don't miss the next #MyCode Genomic Screening and Counseling Program Grand Rounds

"One Size May Not Fit All: Translating Genomic Risk into Individualized Care"

Presented by: Hannah Ryba, MS, CGC, Genetic Counselor I

🗓️October 12th
🕛12:00-1:00 PM

Today, we celebrate the dedicated research administrators who work behind the scenes to help research thrive.

From navigating complex regulations and budgets to supporting researchers, managing grants and keeping projects moving forward, research administrators are essential partners in turning ideas into impact.

Thank you for your expertise, problem-solving, collaboration and unwavering commitment to advancing research. Your work makes a difference every day!

Here’s to the research administrators who make discovery possible. 💫💙👏 #ResearchAdministratorsDay @NCURA

Congratulations to Max Freid Kramer on being named an inaugural fellow of Georgetown’s Blood and Plasma Research Group Fellowship! 👏

This new fellowship supports early-career scholars whose research focuses on blood products and related areas. We’re proud to see Max represent Geisinger in this exciting opportunity and look forward to the impact of his work.

➡️Learn more about the fellowship here: gisme.georgetown.edu/georgetown-blo…